Psoriasis.

Slides:



Advertisements
Similar presentations
PITYRIASIS RUBRA PILARIS (PRP)
Advertisements

Epidemiology, presentation, complication and management.
IDENTIFICATION AND MANAGEMENT
Ramesh Mehay Programme Director (Bradford VTS)
Psoriasis. Definition Chronic plaque psoriasis (psoriasis vulgaris) is a chronic inflammatory skin disease characterised by well demarcated erythematous.
Psoriasis slide A common scaly and inflammatory skin disorder that is both painful and disabling Thought to be an autoimmune disease with a possible genetic.
Papulo-squamous diseases
Pimecrolimus 1% cream in the treatment of facial psoriasis: A 16-week open label study Jacobi A et al. One of authors Braeutigam M belongs to clinical.
Psoriasis Definition: is a chronic, sometimes acute, non- contagious common condition of the skin Definition: is a chronic, sometimes acute, non- contagious.
Tissue Repair Dr. Raid Jastania. What is Repair? When does regeneration occur? When does fibrosis occur? What are the consequences of fibrosis?
Erythema By Dr. Mohamad Nasr Lecturer Of Dermatology & Venereology.
Psoriasis & Skin Cancer
Psoriasis. Definition and causes Definition and causes Types Types GP management GP management Pitfalls Pitfalls Hospital treatments Hospital treatments.
Erythema Multiforme. EM minor & EM with mucosal involvement Self-limited, recurrent disease, usually in young adults No or only a mild prodrome (1 to.
PSORIASIS. Psoriasis is a disease which affects the skin and joints. Psoriasis is a disease which affects the skin and joints.skinjointsskinjoints It.
Psoriasis and Skin Cancer Edward Pritchard. Long Cases You could get these! Last year’s finals! - Patient with recurrent SCC, with no symptoms. History.
Psoriasis داء الصدف.
SHRI GANASAYA NAMAHA. AN UPDATE ON PSORIASIS BY DR. MAHESH MATHUR, MD,DVD,DCP (UK) MD,DVD,DCP (UK)
Psoriasis. Definition and causes Types GP management Pitfalls Hospital treatments Case studies.
Psoriasis. Definition l Psoriasis is a recurrent,chronic,inflammatory disease of the skin characterized by red papules or plaques covered by silvery white.
Rheumatoid Arthritis(RA)
Alexandra Pyle Bsc (Hons) Registered Nurse. What is Psoriasis?  Psoriasis is a chronic inflammatory skin disorder characterised by thickened, scaly plaques.
Psoriasis. Definition and causes Types GP management Pitfalls Hospital treatments.
Atopic & Contact Dermatitis; Scaly Dermatoses Spring Term 2006 Lab Week 3.
 exact cause unknown  defect of the skin that impairs its function as a barrier, combined with an abnormal function of the immune system, are believed.
OUTCOME MEASURES IN PsA: TISSUE ANALYSIS Oliver FitzGerald.
PSORIASIS Ben Basger Basgers Pharmacy North Bondi Pharmacy Practice, The University of Sydney.
Psoriasis and Other Papulosquamous Disease. Definitions – Psoriasis is the most common chronic papulosquamous disease – The classic lesion of psoriasis.
Psoriasis. Definition Psoriasis – Chronic, inflammatory disease of the skin characterized by altered epidermal growth and differentiation with multiple.
Pharmacology-4 PHL 425 Fourth Lecture By Abdelkader Ashour, Ph.D. Phone:
Show your Best III By: Brad Moatz MSIV. Presentation 42 y.o. male presents with R foot pain and h/o psoriasis.
Skin Pathology, Case 4 A 25-year-old male presents to his dermatologist with well-demarcated, scaly, pink to salmon-colored plaques over the elbows. Areas.
Eczema & Psoriasis Dr. Jerald E. Hurdle Kennebec Medical Consultants Waterville, ME
1 Psoriasis. 2 Types of Psoriasis n Nearly 90% of people with psoriasis have plaque-type psoriasis n Less than 10% of people with psoriasis have guttate.
OUTCOME MEASURES IN PsA: IMMUNOHISTOLOGY Oliver FitzGerald.
The power to heal. Types of Skin Disease Diagnosis of Psoriasis Doctors usually diagnose psoriasis after a careful examination of the skin. However, diagnosis.
PSORIASIS BY: Jennifer Teen Health 8 Old Orchard Junior High School.
بسم الله الرحمن الرحيم.
Psoriasis Victoria Lund. Overview Causes skin cells to mature in less than a week (normally it takes days) The immune system send signals to increase.
Psoriasis disease psoriasis  Content  Definition  Name of the causing bacteria  Common types of psoriasis  Diagnosis  causes.
Psoriasis and Other Papulosquamous Disease
Diagnosis and Management of Psoriasis and Psoriatic Arthritis
Psoriasis د. هدف عبدالامير حسن.
By AFSAR FATHIMA Dept. of Pharmacology
Integumentary System Diseases and Abnormal Conditions
Presentation topic Psoriasis Disease
Psoriasis John Sugrue.
INFECTIONS Allergies, Fungal, Bacterial, Viral, Infection, Inflammation, and Genetic.
Department of Dermatology
Lichen Planus.
Psoriatic arthritis (PsA) Clinical features, Diagnosis & Management
Psoriasis داء الصدفية.
Phototherapy in the treatment of inflammatory dermatoses
Psoriasis By: Charissa McKenzie.
A Red Scaly Rash ..
Psoriasis and Skin Cancer
The Multitasking Organ: Recent Insights into Skin Immune Function
The Multitasking Organ: Recent Insights into Skin Immune Function
Dermatology update in common cases and treatment
Clive Tubb CNS Dermatology
Lesson 2: Diseases and Disorders
Kate Blake Lead Nurse Dermatology
Psoriasis By P.Ashwini.
Presentation transcript:

Psoriasis

Background Psoriasis is an inflammatory, noncontagious, genetically determined skin disorder that most commonly appears as inflamed, edematous skin lesions covered with a silvery white scale. Up to 2% of the population develop Ps during their lifetime. Stress, trauma and infections may induce Ps in susceptible individuals.

Risk Factors Ps can be present at any time from the first few weeks of life until 80 or more years of age Most patients experience onset in the third decade of life There is a definite familial tendency to inherit Ps: when one parent is affected, there is a one in four chance of Ps in each child; with two affected parents, the rate is one in two Some genetic linkage between Ps and the HLA-Cw6 phenotype

Pathophysiology The pathological process is a combination of epidermal hyperproliferation and activation of inflammatory pathways with accumulation of inflammatory cells The hyperplasia of the epidermis results from both a shortened epidermal cell cycle (from an average normal turnover of 23 days to 3-5 days) and an increase in the proliferative cell population Autoimmune function Significant evidence is accumulating that psoriasis is an autoimmune disease. Lesions of psoriasis are associated with increased activity of T cells in underlying skin. Guttate psoriasis has been recognized to appear following certain immunologically active events, such as streptococcal pharyngitis, cessation of steroid therapy, and use of antimalaria drugs. Superantigens and T cells Psoriasis is related to excess T-cell activity. Experimental models can be induced by stimulation with streptococcal superantigen, which cross-reacts with dermal collagen. This small peptide has been shown to cause increased activity among T cells in patients with psoriasis but not in control groups. Also of significance is that 2.5% of those with HIV develop psoriasis during the course of the disease

Pathophysiology - Details An infiltrate comprising activated T cells is localized in the dermal papillae of skin and the sublining layer of the joint synovium. Other key cells include various forms of dendritic cells and macrophages; B cells are present but their role is as yet not well defined. These cells generate a number of proinflammatory cytokines, such as tumor necrosis factor (TNF)-alpha, interleukin (IL)-1, and IL-6, which in turn contribute to activation of additional pathogenic cells. In the skin, through the influence of proinflammatory cytokines such as TNF-alpha, keratinocytes proliferate and have prolonged survival, leading to skin thickening and plaque. Proinflammatory cytokines such as TNF-alpha are instrumental in activating endothelial cells to express adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1), and E-selectin (upregulated more in the skin), which promote lymphocyte migration to sites of inflammation. Cutaneous lymphocyte-associated antigen (CLA) is expressed on lymphocytes homing to skin lesions, but not to areas of synovitis. Vascular pathology is similar in both the skin and synovium, characterized by prominent angiogenesis with abnormal tortuous vessels. Upregulation of angiogenic growth factors, partly via the action of TNF-alpha, including vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-beta), platelet-derived growth factor (PDGF), and angiopoietins contribute to this phenomenon. Neovascularization is an important component of the inflammatory, erosive nature of the disease. TNF-alpha also contributes to the increased production of proteases such as matrix metalloproteinases (MMPs), which are involved in cartilage destruction. Abnormal bone remodeling is a key feature of Ps arthritis. Joint-space narrowing and joint erosions occur, as well as osteolysis of both digital tufts and joint areas. However, juxta-articular periosteal new bone formation occurs, as well as ankylosis.

Histopathology – Cardinal Features Marked thickening of the epidermis (acanthosis) Absence of the granular layer Retention of the nuclei in the horny layer (parakeratosis) Accumulations of polymorphs in the horny layer (Munro’s microabscesses) Dilated capillary loops in the upper dermis.

Clinical Patterns of Psoriasis Classical plaque (psoriasis vulgaris) Scalp Ps Nail Ps Guttate Flexural “Brittle” Erythrodermic Acute pustular (of von Zumbusch) Chronic palmoplantar pustular (of Barber) Arthropathic Ps

Classical Plaque Psoriasis (psoriasis vulgaris) The commonest pattern Single or multiple red plaques (papules) varying from a few millimeters to several centimeters in diameter with a scaly surface Psoriatic step-by-step triad obtained by scraping: silvery (stearin) staining terminal (wet) plate cappilary-point haemorrhage (Auspitz sign) Predilection for extensor surfaces: the knees, the elbows and the base of the spine Lesions are often symmetrical The scalp and nails are often affected and the arthropathy may also occur Psoriatic plaques may appear at the site of trauma or scarring – Koebner or isomorphic phenomenon

Scalp Psoriasis Scalp may be affected alone Can be difficult to distinguish from severe seborrhoeic dermatitis Lesions vary from one or two plaques to a sheet of thick scale covering the whole scalp surface Often, very thick plaques develop, especially at the occiput (nape) Even decades of persistent scalp Ps have remarkable little effect on the hair, but hair loss is not as uncommon as previously stated.

Nail Psoriasis Nail abnormalities are frequent and are almost always present in arthropathic Ps Two common findings can occur together or alone: pitting and onycholysis. Psoriatic nail pits are relatively large and irregularly arranged Onycholysis (lifting of the nail plate) initially produces a dull red area with a salmon-pink rim, but the nail becomes brown or yellow in time.

Guttate Psoriasis Often develops suddenly and may follow an infection, especially a streptococcal sore throat It is common in adolescents and young adults Lesions are about one centimeter in diameter and are usually round in shape Itch is common Lesions can enlarge and become plaque Ps

Flexural Psoriasis (inverse psoriasis) Lesions may occur in the groin, natal cleft, axillae, umbilicus, submammary and gluteal folds Psoriatic balanitis is a form of inverse Ps, that is represented by erythematous plaques on the glans penis Maceration inevitably occurs, and the scale surface is often lost, leaving a beefy erythematous appearance It is often itchy

Brittle Psoriasis (instable Ps) Lesions consist of thin, irritable scaly areas Lesions may arise de novo or develop suddenly in a patient whose Ps has been stable for years Systemic steroid therapy and potent topical steroids can induce stable Ps to become “brittle”\ Lesions may rapidly generalize, leading to erythroderma or acute pustular Ps

Erythrodermic Psoriasis When psoriatic plaques merge to involve most, or all, of the skin a state of erythroderma or exfoliative dermatitis results; it may appear de novo The skin is red, hot and scaly; hair and nail loss can develop; itching is severe There may be a generalized lymphadenopathy There is a loss of control of temperature regulation accompanied by bouts of shivering Complications: cardiac failure, renal failure, sudden death due to central hypothermia.

Acute Pustular Psoriasis (of von Zumbusch) This is a life-threatening condition Patients with or without pre-existing Ps suddenly develop widespread erythema, superimposed on which are pustules Pustules can coalesce into lakes of pus (Kogoj-Lapierre pustules) The pustules are sterile The patient has a high, swinging fever and is toxic and unwell, with a leucocytosis If untreated, may die, often of secondary infections.

Chronic Palmo-Plantar Psoriasis (of Barber) It is unusual for patients to have chronic palmo-plantar pustulosis in association with other forms of Ps The typical changes consist of erythematous patches with numerous pustules These gradually change into brown, scaly spots and peel off Lesions may involve a small area of one hand or foot, or cover the entire surface of both palms and soles This may lead to considerable disability

Arthropathic Psoriasis One of the most unpleasant complication of Ps is arthropathy, affecting up to 10% of psoriatics There are four basic clinical patterns: distal interphalangeal joint involvement (DIP form) seronegative rheumatoid-like joint changes large joint mono- or polyathropathy spondylitis Psoriatic arthropathy is erosive and may result in joint destruction Psoriatics who develop the spondylitic for are usually HLA B27 positive, as in Reiter’s syndrome.

Treatment of Psoriasis It is an old adage that if there are many treatments for a disease, none works perfectly – this is certainly true of psoriasis Although each modality is useful in some patients, all represent a compromise in terms of safety, effectiveness and convenience Many patients require a regimen of different agents for different sites at different times.

Treating Psoriasis Topical Agents Emollients Tar Salicylic acid Topical steroids Dithranol (anthralin) Vitamin D analogues (calcipotriol, tacalcitol, etc) Vitamin A analogues (tretinoin, tazaroten, etc.) Ultraviolet radiation (UVA, UVB)

Treating Psoriasis Systemic Agents PUVA (psoralen + ultraviolet A) Retinoids (acitretin, etretinate, isotretinoin) Cytotoxics (methotrexate, azathioprine, hydroxiurea) Systemic steroids Ciclosporin TNFα inhibitors (infliximab, etanarcept, etc.)